This week, we take a look at the state of health technology venture capital and angel funding, through the first three quarters of 2013. Analyzing some publicly available data from our friends at CrunchBase, we break down national aggregate statistics for deals in the HealthTech space by stage of funding (Angel, Series A, Series B, and Series C+). It is important to note that these figures do not include any biotechnology fundings.
AlleyWatch is up for a $250k grant. We could use your vote. It only takes 2 seconds. We promise. Vote here.
|Health Tech in Aggregate Across All Rounds||National|
|# of deals||83|
|# of deals||37|
|# of deals||25|
|# of deals||13|
|# of deals||8|
For your tweeting convenience:
$571.3M has been invested in #HealthTech #startups in 2013 Tweet this
Average HealthTech Angel round in the US in 2013 is $478k Tweet this
Average HealthTech A round in the US in 2013 is $6.98M Tweet this
Average HealthTech Series B round in the US in 2013 is $17.01M Tweet this
Average HealthTech Series C+ round in the US in 2013 is $19.75M Tweet this
Data credit: CC by CrunchBase